NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10 To Go Ex-Dividend On May 1st, 2024 With 0.28851 USD Dividend Per Share
April 13th - $NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10(NVZMY.US)$ is trading ex-dividend on May 1st, 2024. Shareholders of record on May 2nd, 2024 will receive 0.28851 USD dividend
Is CalMaine Foods (CALM) Stock Outpacing Its Basic Materials Peers This Year?
MATV or NVZMY: Which Is the Better Value Stock Right Now?
Are Basic Materials Stocks Lagging Novozymes (NVZMY) This Year?
MATV Vs. NVZMY: Which Stock Is the Better Value Option?
DJ Symbol for Novozymes A/S (NZYM-B.KO) Now NSIS-B.KO
DJ Symbol for Novozymes A/S (NZYM-B.KO) Now NSIS-B.KO
Resolutions From the Extraordinary Shareholders' Meeting 2024
Is Novozymes (NVZMY) Stock Outpacing Its Basic Materials Peers This Year?
MATV Vs. NVZMY: Which Stock Should Value Investors Buy Now?
Novo Nordisk's Parent Eyes $7B Annual Investments by 2030: FT
Settlement of the Combination of Novozymes and Chr. Hansen Holding Successfully Completed
Recap: Novozymes Q4 Earnings
Novozymes (OTC:NVZMY) reported its Q4 earnings results on Thursday, February 1, 2024 at 03:00 AM.Here's what investors need to know about the announcement.EarningsNovozymes missed estimated earnings b
Legacy Novozymes Delivers Solid Last Full-year Results
Results Update for 2023 – Unaudited
Total Number of Voting Rights and Capital on January 31, 2024
Major Shareholder Announcement
Novozymes's Solutions Boosted by AI, CEO Says -- Market Talk
1126 GMT - Danish biotechnology company Novozymes uses artificial intelligence to speed up production processes and understand the market and its needs, Chief Executive Ester Baiget says during a Worl
EU: Decision Is Conditional Upon Full Compliance With Commitments
EU: Decision Is Conditional Upon Full Compliance With Commitments
EU: Parties Offered to Divest Some Operations to Address Competition Concerns
EU: Parties Offered to Divest Some Operations to Address Competition Concerns
EU Approves Novozymes and Chr. Hansen Merger, Subject to Conditions
EU Approves Novozymes and Chr. Hansen Merger, Subject to Conditions
No Data